Project Team – Coordinating centre (Peter MacCallum)
Penelope is Head of Behavioural Science in Cancer, the Department of Cancer Experiences Research at Peter Mac, and Professor of Health Psychology in the Department of Psychology at Swinburne University. Professor Schofield has amassed over $19 million in funding for 56 peer-reviewed grants where she was Chief Investigator for 40 of them.
Natalie is Project Manager of the Navigate trial and a Research Nurse in cancer trials and behavioural science research. Her main areas of interest are digital health initiatives and online recruitment methods.
Sherine is a Research Assistant on the Navigate trial. Her main area of interest is in developing and evaluating digital health initiatives to educate, and improve users’ health and wellbeing. She is also completing her PhD at the University of Melbourne.
Research Assistant at Peter MacCallum Cancer Centre
Sabina is a Neuroscience and Psychology student at Swinburne University, who is currently undertaking her placement as a Research Assistant on the Navigate trial.
Alan is the Navigate trial’s consumer representative. He is a passionate advocate for men's health and wellbeing, with a particular focus on prostate cancer. Alan is also an ex-veteran, and has been involved with the Navigate trial since its inception.
Peter MacCallum Cancer Centre
Declan is a Consultant Urological Surgeon and Director of Genitourinary (GU) Oncology and Robotic Surgery at the Peter MacCallum Cancer Centre. He has a strong academic background and has published extensively in the field of minimally-invasive urology for the management of prostate, renal and bladder cancer.
Jeremy is a Consultant Urologist and Director of Clinical Research of the Urology Unit at Alfred Health. He has conducted practice-changing research and published widely on performing prostate biopsy via the skin instead of the rectum, reducing the infection risk to near-zero.
Jeremy is Director of Research, Alfred Health Radiation Oncology, where he has a clinical practice looking after men with prostate cancer. He is Chairman, Cancer Council of Victoria, Deputy Chair, Cancer Council Australia, and on the Council of the Faculty of Radiation Oncology. He helps lead the Prostate Cancer Outcomes Registry-Australia and New Zealand (PCOR-ANZ) based at Monash University.
Cabrini Hospital / Australian Urology Associates
Mark is a urologist and uro-oncologist within the multidisciplinary urology group Australian Urology Associates. He is the Academic Director of Urology, Cabrini Health , Professor, Department of surgery , Faculty of Medicine, Monash University, Urology council member, Royal Australasian College of Surgeons, and Board member of Prostate Cancer Foundation of Australia. He is also a past President of the Urological Society of Australia and New Zealand and sits on various Government health policy committees.
Nathan is a urological surgeon and oncologist at the Olivia Newton-John Institute for Cancer Research at the Austin Hospital. He also has appointments at the Peter MacCallum Cancer Centre and at The University of Melbourne Department of Surgery.
Kevin is Deputy Head of Urology at Western Health and also has a public appointment at Monash health with an interest in Uro-oncology and minimally invasive surgery. He is fellowship trained in Robotic prostatic surgery and has a keen interest in training urology surgeons of the future.
Cindy Ogluszko provides education and support to prostate cancer patients and their families through Nurse led clinics and phone consultations. She has special interests in Men’s sexual health, offering support, education and treatment management plans in a nurse led sexual health clinic at Footscray Hospital.
Wesley Urology Clinic
John is sub-specialised in the surgical management of prostate and bladder cancer. He is involved in the academic teaching program of students at Wesley Hospital and Royal Brisbane Woman’s Hospital and is also a surgical supervisor for urology training registrars at the Royal Brisbane & Women’s Hospital.
University of Sydney
Ilona is Associate Professor in Health Psychology, and Deputy Director of Centre for Evidence-based CeMPED, at the University of Sydney. As a research psychologist, she has over 20 years’ experience conducting research in psycho-oncology and is internationally recognised for her work on medical communication and treatment decision-making. To date, Ilona has developed and evaluated 15 decision-making resources and communication skills training modules for cancer patients, family and clinicians.
Suzanne is Dean of the Faculty of Health at the University of Technology Sydney. She is a health psychologist and registered nurse who has worked as a practitioner and researcher in psychological support for people with cancer for over 30 years.
Lawrence is an Professor in the School of Science, and the Associate Dean and Discipline Head of Computer Science and IT at RMIT University. His research interests include spoken dialogue and speech interfaces, biomedical and health analytics, and Artificial Intelligence in general.
Byron Fisher is an ICT professional specialising in Data analysis and DevOps. Byron uses the entirety of his knowledge to support and lead the future of ICT professionals throughout their time at RMIT University. His research interests include clinical data analysis, drone machine learning, blockchain fintech, and data mining in general.
Ben Luxford is an ICT professional specialising in Corporate systems development and DevOps. Ben builds performant applications and designs fast data transportation processes. He is interested in Data mining, AI/ML process efficiency and sociological impacts of technology. He is an integral member of the technical team for the Navigate trial.
Louisa is a mid-career researcher with 15 years’ experience as a health economist and public health researcher. Her research is focused on economic evaluation, economic modelling, statistical analysis of cost data, study design and research methods for health economics.
University of Queensland
Frank is an urologist and academic in the field of prostate cancer. He has been instrumental in supporting the development of a strong research culture in prostate cancer in Australia and in developing collaborative research programs between clinicians, molecular and behavioural scientists.